Whatever happened to the second law of thermodynamics?
Dear Sir:
We found the recent review by Buchholz and Schoeller (1) to be surprising in several ways. First, there was no reference to our recent review "Thermodynamics and Metabolic Advantage of Weight Loss Diets" (2) , which addressed the same subject but included a more comprehensive set of references and thereby strengthened Buchholz and Schoeller's observation that high-protein, low-carbohydrate diets frequently lead to greater weight loss calorie-for-calorie than do isocaloric diets of different composition (metabolic advantage). Still more surprising was that, in opposition to these experimental observations, they insisted that "a calorie is a calorie" anyway and invoked the first law of thermodynamics. In our own review (2) we pointed out that one cannot ignore 1) the second law of thermodynamics and 2) the fact that living organisms are open systems, far from equilibrium, and therefore subject to different efficiencies depending on metabolic path.
The second law says that there is a physical parameter called "entropy," which we identify with disorder or inefficiency and, whereas energy is always conserved, entropy is not (3) . In any real (irreversible) process, entropy increases and no process is perfectly efficient. The consequence is that conservation of energy (ie, the first law) is maintained by exporting high-entropy compounds (principally carbon dioxide and water) into the environment. The extent to which energy and matter are distributed among heat, chemical bonds, work, and the excreted products is determined by the specific metabolic pathway used. In our review, we presented plausible mechanisms by which dietary composition can lead to different pathways of different efficiencies.
The first law of thermodynamics never exists in the absence of the second law. Both laws are inviolate, and they must be applied correctly.
Reply to AH Manninen and to RD Feinman and EJ Fine
We thank Manninen and Feinman and Fine for their interest in our review, "Is a Calorie a Calorie?" (1) . These 2 letters correctly point out that there are indeed some differences between the energetics of human metabolism and the measures of heat release of nutrients in a bomb calorimeter. We agree with the known concept that the metabolic route through which carbon flows to carbon dioxide, the concentrations of substrates, as well as entropy can all slightly alter the efficiency of ATP production in humans (2) . This concept, however, does not automatically mean that these differences constitute a quantitatively plausible mechanism that would explain the differences in weight loss observed with a high-protein, energy-restricted diet relative to a low-fat, energy-restricted diet.
Rather than relying on a theoretical treatment of metabolic efficiencies, as did Feinman and Fine, we reviewed studies in which known experimental diets were fed to subjects under laboratory conditions to test whether energy expenditure was actually higher with a low-carbohydrate diet than with a high-fat diet. In studies in which protein intake was held constant and fat was substituted for carbohydrate, the difference in 24-h energy expenditure between the high-carbohydrate and high-fat diets was not different from zero (x : Ҁ19 Ȁ 54 kcal/d). However, as clearly stated in our review, when the protein intake was not held constant but rather increased from 15% to 30 -35% of energy, 24-h energy expenditure did increase. We determined, however, that the increase would be only Ȃ41 kcal/d for a 1500-kcal/d energy-restricted diet. This would only increase weight loss by Ȃ0.04 kg/wk, or 0.44 kg over a 12-wk course of weight-loss treatment. It should be noted that this is less than the 95 kcal/d calculated theoretically by Feinman and Fine, and it has the advantage of being based on experimental data. Thus, we do not disagree with Feinman and Fine from the perspective of pure thermodynamics; in fact, we presented evidence at the whole-body level that supports their point. However, we found the experimentally measured differences in 24-h energy expenditure, between subjects who followed a high-protein diet compared with those who followed a high-carbohydrate diet, to be too small to satisfactorily account for the differences in weight loss observed after 12 wk of treatment with these 2 diets. Thus, this is not a plausible mechanism to account for the observed increased weight loss. The experimental data on energy expenditure provide evidence of only a minimal metabolic advantage for low-carbohydrate diets.
We do apologize for not having cited Feinman and Fine's detailed and well-written review, but the journal in which it was published appears to be new and thus is not yet indexed in common biomedical databases. Fructose misuse, the obesity epidemic, the special problems of the child, and a call to action Dear Sir:
Andrea
We have failed our children (1). The surging worldwide obesity epidemic is catastrophic enough, but look at the steady stream of bad news hitting our biochemically immature little ones: both adultonset diabetes and nonalcoholic fatty liver disease (2) as early as the age of 4 y, a great rise in the incidence of pertussis and asthma, and, in the mental area, an alarming increase in autism, ritalin use, bipolar disorder, anxiety, and the use of antidepressants in preschool children. With a lifetime to progress to even more-serious problems, the problems of children are far worse than most people seem to realize.
Fortunately, the solution is in the scientific literature. The article by Bray et al (3) in the April issue of the Journal advanced the search for a solution with emphasis on fructose and beverages, but there were errors of commission and of omission in this article. In Figure  1 of Bray et al's article, according to their reference 35, the most recent data point for the percentage prevalence of obesity should be 30.9%, not 26%, and at least some of the data points for the prevalence of overweight should be much higher. The correct values emphasize the recent rapid rise in obesity and increase the urgency of the problem.
Bray et al made good use of the data in their reference 34, but they seemed to miss the extra significance for the child represented by the data in Figure 6 in the 1993 article by Park and Yetley (4) . The mean daily intake of fructose (in g/kg body wt) from birth to age 80 y is shown in Figure 6 . At age 20 y, the daily intake of total fructose was Ȃ0.62 g/kg, and it slowly decreased with age, whereas the naturally occurring fructose intake at age 20 y was Ȃ0.2 g/kg. At ages 20 y, however, it was astonishing that the daily intake of total fructose remained 1.9 g/kg body wt from near birth to about the age of 4 y. Through the years of their postnatal brain growth spurt, infants and toddlers are fed 10 times the amount of naturally occurring fructose ingested by adults.
What is a reasonable guess for the daily intake of total fructose for an infant from the Stone Age? Zero. They must have been fed mother's milk, the sugar in which is lactose, which digests to galactose and glucose only. Note that the ratio between the amount of fructose our infants are being fed today and the amount they were fed when our genes were adapting to the environment approaches infinity.
Bray et al pointed out many differences between fructose and glucose, with more troubles from fructose. "It is becoming increasingly clear that soft drink consumption may be an important contributor to the epidemic of obesity, in part through the consumption of larger portion sizes of these beverages and through the increased intake of fructose from high-fructose corn syrup and sucrose." Bray et al referenced Elliott et al (5), who cited more differences between glucose and fructose in their major review. They concluded in part, "...on the basis of the available data regarding the endocrine and metabolic effects of consuming large quantities of fructose and the potential to exacerbate components of the insulin resistance syndrome, it is preferable to primarily consume dietary carbohydrates in the form of glucose (free glucose and starch)." Others concluded that, "if plasma triacylglycerols are a risk factor for cardiac disease, then diets high in fructose may be undesirable...efforts to reduce fructose intake should focus on reducing the amount of fructose added to beverages and foods in the American diet. A reduction in added fructose would be facilitated by an acceptable replacement sugar. Such a sugar might be glucose (6) ." Wharton and Hampl (7) concluded that, "Native Americans face some of the highest rates of obesity and diabetes in the world...little attention has been paid to reducing fructose, particularly in the form of HFCS [high-fructose corn syrup] in beverages...numerous studies have documented that beverages are a leading contributor to energy intakes among Native Americans... one approach may be by promoting sugar-free beverages." The titles of the studies by Levi et al (8) and Suarez et al (9) point to additional alarming troubles associated with fructose intake.
Basic biochemistry indicates that glucose and fructose have different chemical properties. Of the 3 major sugars that digest into the human bloodstream, the 2 that are vital to humans, galactose and glucose, are both aldoses, whereas fructose is a ketose-this sugar is the one that the human liver tries hard to keep at essentially a zero concentration in the blood. Murray et al (10) wrote that, "Biomedically, glucose is the most important monosaccharide and ingestion of large quantities of fructose has profound metabolic consequences ...because it bypasses the regulatory step catalyzed by phosphofructokinase. This allows fructose to flood the pathways in the liver, leading to enhanced fatty acid synthesis, increased esterification of fatty acids, and increased VLDL secretion, which may raise serum triacylglycerols and ultimately raise LDL cholesterol concentrations."
Could fructose contribute to nonalcoholic fatty liver disease? With all the documented troubles from fructose, it is clear that the low glycemic index of fructose is misleading at best. The main source of fructose for infants and toddlers is fruit juice and soda. The nutrition-facts labels indicate that both sources are essentially the same, that is, sugar water that digests to nearly equal amounts of glucose and fructose. Of course, more trouble results from the faster sugar ingestion from a water solution than from sugar in solid foods, as noted by Bray et al.
Three summarizing facts call for immediate resolution: 1) we are flooding our infants and toddlers with fructose, 2) we are doing this through their entire postnatal brain growth spurt, and 3) infants and toddlers are being flooded with severe health problems, including brain disorders. How effective is the liver of infants and toddlers in keeping fructose out of their blood? How effective is their bloodbrain barrier in keeping fructose out of their brain? Would there be any harm from withholding fructose until an age at which this population could handle whole fruit? How much does the surging worldwide sale of sugar water contribute to the surging obesity epidemic? Should fructose be withdrawn from the list of "generally recognized as safe" substances? We thank Krilanovich for pointing out the error in our Figure 1 . He is absolutely correct that the prevalence of obesity was 30.5% in 2000, not 26%. We submitted an amended figure to the Journal, which was published in response to an earlier letter (2) . As Krilanovich noted, the correct value makes the rise in the prevalence rates of obesity more evident and the temporal relation of the increasing use of HFCS clearer.
Nicholas J Krilanovich
Since our paper was published, a subsequent analysis of carbohydrate intake in relation to the prevalence of diabetes was published by Gross et al (3) . Their observations dovetail with ours. They showed a decline in carbohydrate intake of from 500 g per capita in 1910 to 362 g per capita during the first three-quarters of the 20th century. Thereafter, carbohydrate intake returned to the same level as earlier in the 20th century. HFCS represents almost all of the increased carbohydrate during this latter period. Their study also nicely highlights the temporal relation of this change in carbohydrate intake with the rising incidence of diabetes.
Nature prefers glucose and rejects fructose. Fructose does not enter the brain or pancreas to any appreciable degree. Yet fructose is considerably sweeter than either glucose or sucrose. As Krilanovich points out, infants and young children in our society are exposed to higher intakes of fructose than were our ancestors. The fructose from HFCS used in beverages differs from the fructose combined to form sucrose in 2 ways. First, it is free fructose and as such is sweeter molecule for molecule than is sucrose or glucose-the other half of the sucrose molecule. In addition, HFCS solutions have a higher osmotic pressure than do equimolar sucrose solutions, because there are 2 molecules in the HFCS solution (fructose and glucose) compared with a single molecule in sucrose. This enhanced sweetness and high osmolarity may serve to stimulate the taste receptors more intensely and to "imprint" this intense taste in the plastic neurocircuitry of young and growing brains, a change that may increase the desire for sweet taste throughout life. If this is even a remote possibility, the suggestion by Krilanovich to eliminate the exposure of infants and children to fructose might be worth serious consideration. As we know, intrauterine exposure to maternal smoking (4) or diabetes (5) enhances the risk of obesity and overweight later in life. Thus, we support Krilanovich in encouraging a review of whether exposure to fructose either as HFCS or in sucrose during the early years of life may play an important role in the current epidemic of obesity in children (6) . If there is even a suggestion that this is so, then access by infants and young children to beverages with fructose should be curtailed during critical periods of brain growth and development.
George Bray
Pennington Biomedical Research Center 6400 Perkins Road Baton Rouge, LA 70808-4124 E-mail: brayga@pbrc.edu
Samara Nielsen Barry Popkin
University of North Carolina-Chapel Hill Chapel Hill, NC
Vitamin B-6 status and coronary artery disease
We found the recent article by Friso et al (1) potentially intriguing. An association between vitamin B-6 status and coronary artery disease (CAD) in humans has been discussed for decades, but to date there has been no satisfactory biochemical explanation for this association (see, for example, reference 2). In their study, Friso et al stated " . . . we excluded subjects with conditions known to influence B-vitamin metabolism . . ."; however, they included smokers and nonsmokers in both their CAD-free subjects and their CAD patients (see Table 1 in their article). Although they further stated that they performed multivariate logistic regression analyses that controlled for smoking and other indexes, such a regression analysis does not preclude an increasing percentage of smokers in each of the successive quartiles of pyridoxal-5'-phosphate (PLP) concentrations (see Figure 1 in their article). Because smoking is a well-documented determinant of PLP concentrations (3-6), we would have anticipated that the PLP data would also have been stratified by smoking load or that the incidence of smokers and nonsmokers would have been reported for each quartile in Figure 1 . These data should be fairly easy for the authors to check.
In addition, more information on the intake of vitamin B-6 from the diet and from supplements needs to be provided. Moreover, because of the inverse association between circulating PLP concentrations and the activity of plasma alkaline phosphatase, the activity of alkaline phosphatase needs to be provided for both groups of subjects. After these analyses, if the associations of PLP with C-reactive protein and fibrinogen continue to hold up, then a functional role for vitamin B-6 in the prevention of CAD may finally be at hand.
Reply to RD Reynolds and JE Leklem
We are thankful to Reynolds and Leklem for their interest in our work on vitamin B-6 and coronary artery disease (CAD) risk (1). We certainly coincide in the opinion that smoking is a well-documented determinant of pyridoxal-5'-phosphate (PLP) concentrations (2-5), an opinion that we also expressed in our first report suggesting an inverse relation between plasma PLP and C-reactive protein (6) . However, in the present study, no difference in PLP concentrations was detected between smokers and nonsmokers either in the whole population study (P ҃ 0.21) or within groups of subjects with or without CAD (P ҃ 0.68 and P ҃ 0.54, respectively). Furthermore, no significant difference in the percentage of smokers across increasing quartiles of PLP concentrations was observed (P ҃ 0.09).
Nevertheless, as affirmed in the article, we conducted multivariate logistic regression analyses to control for, among other factors, smoking status. Because smoking is a well-known risk factor for CAD, it could have been a strong confounder in the estimate of the independent association between low PLP concentrations and CAD risk, and estimation of this association was one of the primary aims of the study. Analysis for potential interactions, moreover, showed that CAD risk, as a result of low PLP, was additive when considered in combination with smoking status. We agree with Reynolds and Leklem that an evaluation of smoking load could be of interest, but such data were not available.
The existence of an inverse relation between plasma PLP concentrations and the activity of alkaline phosphatase is indeed known. In our case-control study for the assessment of CAD risk, however, there was no evident reason to test for alkaline phosphatase, which, we concur with Reynolds and Leklem, could have a stronger effect, particularly in certain diseases (7) . We are confident that our report highlights a potentially important role of PLP in CAD, although mechanistic studies are certainly required to clarify the biochemicalmolecular basis of this association.
Simonetta Friso Domenico Girelli Roberto Corrocher
Department of Clinical and Experimental Medicine University of Verona School of Medicine Policlinico "GB Rossi" P le LA Scuro 10 37134 Verona Italy E-mail: simonetta.friso@univr.it
A modified regression model to adjust for intraindividual variation in serum biomarker concentrations
I read with interest the recent article by Gillespie et al (1) suggesting a new method for predicting the mean retinol concentration of a person from a single measurement. The basic idea is to adjust for intraindividual variation. Gillespie et al applied the method to reduce prevalence estimates of inadequate serum retinol concentrations by using laboratory-quality data and a subsample of repeated measurements. The centerpiece of the method is the linear regression model,
where X is the individual mean of repeated measurements, and X 1 is the first measurement of retinol concentration. However, the chosen regression model did not adequately address the problem of eliminating the intraindividual variance component. First, it is possible that the estimate of the slope parameter ␤ 1 is larger than 1, which means that the prevalence estimate of inadequate concentrations will be exaggerated. To see this failure, consider a simple hypothetical example of 3 persons with first retinol concentration measurements of 1.9, 2.0, and 2.1 mol/L and corresponding second retinol concentration measurements of 1.7, 2.0, and 2.3 mol/L. The resulting individual means are 1.8, 2.0, and 2.2 mol/L, and the estimate for ␤ 1 is equal to 2. In general, the proposed method may fail if both measurements are highly correlated and the second LETTERS TO THE EDITOR concentrations vary more than the first ones. Instead of regression on the first measurement, all single measurements should be included in the model. If this is done, the estimated regression slope cannot be larger than 1, which can be proven. In the hypothetical example, the estimate is 0.8 if all 6 measurements are used.
Second, the linear regression model should predict a person's "usual" serum retinol concentration defined as the long-term daily average. Although Gillespie et al adopt a similar interpretation of their approach, they actually use the mean of only 2 measurements as the dependent variable in the model. Because the mean of 2 repeated measurements still has an intraindividual variance component, this component must be subtracted before regression analysis is applied. Principally, the usual retinol concentration has to be estimated in a preliminary step. The problem of estimating usual or long-term exposure by repeated short-term measurements has been intensively studied in food-consumption and environmental surveys, and several statistical methods aimed at eliminating the intraindividual variance component are available (2-4) .
In summary, I propose applying a modified regression model with another dependent variable and another independent variable. Regression of the estimated usual retinol concentration on a single concentration by using all single measurements allows elimination of the distracting effect of intraindividual variation. Applying this modified model should yield lower prevalence estimates of inadequate serum retinol concentrations than those obtained by Gillespie et al.
Kurt Hoffmann

Department of Epidemiology German Institute of Human Nutrition
Arthur-Scheunert-Allee 114-116 14558 Nuthetal Germany E-mail: khoff@mail.dife.de
Reply to K Hoffmann
We appreciate Hoffmann's interest in our article describing the intraindividual variation in serum retinol concentrations. The first point that he raises is that the linear model we used does not eliminate the intraindividual variation component in the observed means. The purpose of the linear model in our analysis was to address the "regression to the mean effect" in the serum constituent. The model was not intended to eliminate the intraindividual variance but was instead intended to account for the theoretical shift of a person's mean concentration toward the population mean, which is unobservable given only 2 serum samples per subject. Hoffmann suggests that the linear model may fail if both serum concentrations are highly correlated and the second measure varies more than the first, and he offers an example in which a linear model does fail. We investigated the variance issue and found that although the 2 concentrations were highly correlated in our data, the sample variance for the 2 concentrations did not differ significantly (F test P value 0.10). As discussed in our article, the linear model was appropriate for this particular US representative sample. Furthermore, we discussed that neither this model nor our results could be extrapolated beyond the US population to other populations or to other serum constituents.
Second, Hoffmann states that the "usual" retinol concentration should be estimated in a preliminary step because the intraindividual mean has an intraindividual variance component. In our article, we estimated the intraindividual variance in a separate step, on the basis of the observed intraindividual variance between the 2 concentrations for each subject. The mean estimated by using the linear equation indeed has its own variance, which we accounted for by incorporating the intraindividual CV in the construction of CIs around the estimated means.
In summary, Hoffmann suggests a modified regression model incorporating both serum concentrations as independent variables and "subtracting" the intraindividual variation from the observed mean for the dependent variable in the model. Although we do not dispute the potential merits of such a model in other applications, it would not be useful in assessing patients' nutritional status at the clinical level, where there is often only one serum concentration available. Our purpose was to estimate the intraindividual variance based on 2 observed concentrations, to incorporate a linear model to adjust for the unobservable regression to the mean effect, and most importantly, to allow for estimation at the clinical level of a person's "true" mean serum retinol concentration and a CI for that estimate based on a single serum concentration.
Cathleen Gillespie Ralph Donehoo Mary Serdula
Centers for Disease Control and Prevention 4770 Buford Highway, NE Mailstop K-26 Atlanta, GA 30341-3724 E-mail: cgillespie@cdc.gov
How to consider low serum vitamin D as a risk factor for insulin resistance?
Chiu et al (1) provide elegant evidence that the 25-hydroxyvitamin D [25(OH)D] concentration has a positive relation to insulin sensitivity in healthy, nearly normal-weight, glucosetolerant subjects. They conclude that a low concentration of 25(OH)D can be an independent risk factor for metabolic syndrome in large populations.
We have some concerns. First, the authors recognize the significant relation between serum concentrations of 25(OH)D and latitude in the European population (2) . Thus, we should infer a correlation between latitude and insulin sensitivity. The European Group of Insulin Resistance failed to find any correlation between latitude and insulin sensitivity in a cohort of 1146 European subjects (3). Moreover, because concentrations of 25(OH)D depend on sunlight exposure (4, 5) , for each patient we could find seasonal differences in insulin sensitivity. The authors report a marginal effect (P ҃ 0.0729) of season on 25(OH)D, which could be biased by the prevalence of subjects studied or by the time definition for each season.
Second, the incidence of metabolic syndrome was 30% in 47 subjects with hypovitaminosis D (20 ng/mL) compared with 11% in 79 subjects with normal concentrations of 25(OH)D. Because the 25(OH)D concentration was an independent predictor for BMI, was BMI equally distributed between the 2 groups? Moreover, the authors did not provide data on body composition. The percentage of fat is inversely related to the serum 25(OH)D concentration (5) . A high percentage of body fat could play a key role in explaining the relation between low serum vitamin D concentrations and insulin resistance.
The last, but main, concern comes from evidence of hypovitaminosis D coupled with normal insulin sensitivity in obese subjects undergoing biliopancreatic diversion (BPD), a type of bariatric surgery (6) . BPD basically causes weight loss through severe lipid malabsorption (6) and leads to mild-to-severe hypocalcemia, low concentrations of vitamin D, and hyperparathyroidism in large cohorts of subjects (7, 8) . BPD patients do not have serum 25(OH)D concentrations that are higher than those of obese subjects (9) . However, BPD increases insulin sensitivity up to 3-fold with respect to baseline (10) and significantly reduces fat mass and cardiovascular disease risk (11) . With regard to the recent report by Chiu et al (1) , which shows a direct correlation between plasma 25-hydroxyvitamin D and insulin sensitivity, it is surprising that the authors do not cite their own highly germane study, which shows that insulin sensitivity correlates inversely with plasma parathyroid hormone (PTH) in healthy volunteers (2) . There is reason to suspect that mild secondary hyperparathyroidism may be the chief mediator of the insulin resistance associated with poor vitamin D status (3) . PTH can increase free intracellular calcium concentrations in key insulin target tissues, including adipocytes and skeletal muscle (4, 5) . Reusch et al (6) have shown that moderate increases in free intracellular calcium can compromise the efficiency of insulin-stimulated glucose uptake, not by interfering with the activation of PI3K-Akt but rather by suppressing the activation of a phosphatase required for optimal function of GLUT-4. Indeed, both primary and secondary hyperparathyroidism are characterized by reduced insulin sensitivity (3). The findings of Chiu et al's group suggest that the relatively modest increases in plasma PTH associated with suboptimal vitamin D status may likewise have implications for insulin function.
Melania Manco
If this thesis is correct, one would expect supplemental calcium to affect insulin sensitivity, at least in subjects with mildly elevated PTH. In fact, there are 2 controlled studies that showed that supplemental calcium improves insulin sensitivity in hypertensive persons (7, 8) . Moreover, a relatively high calcium intake has been linked to a reduced risk of diabetes in a prospective epidemiologic study (9) . Chiu et al's article cites the scarce findings relevant to the effect of supplemental vitamin D on insulin sensitivity. It would be of great interest to determine whether effective supplemental intakes of vitamin D (10)-with or without concurrent supplemental calciumcan indeed improve the insulin sensitivity of groups with mediocre vitamin D status.
Because it seems unlikely that insulin function would influence 25-hydroxyvitamin D concentrations, it is reasonable to presume that the latter is influencing the former. However, a skeptic might note that frequent outdoor exercise would tend to improve both vitamin D status and insulin sensitivity and thus might account for the correlation observed by Chiu et al. To discount this argument, it would be helpful if the authors assessed and analyzed the exercise habits of their subjects.
Mark F McCarty
LETTERS TO THE EDITOR
Study suggest that self-reported dental status among wellfunctioning and community-dwelling older adults is very reliable. Around 96% and 86% of the Health ABC dental and periodontal examination participants correctly reported edentulism and denture use, respectively. With additional follow-up of both self-reported oral health and examination data obtained in the Health ABC study, we hope to understand how oral health affects nutritional status over time as the health and function of this cohort decline with age.
